+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Insulin Delivery Devices Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026

  • ID: 5147620
  • Report
  • September 2020
  • Region: Global
  • 150 pages
  • OG Analysis

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Biocon Ltd. Eli Lilly
  • Medtronic
  • Novo Nordisk
  • Sanofi
  • MORE
The study predicts the short term and long term trends that can shape the future of the Insulin Delivery Devices market including the COVID-19 pandemic implications for the Insulin Delivery Devices industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Insulin Delivery Devices market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Insulin Delivery Devices Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Insulin Delivery Devices market forecast and Insulin Delivery Devices market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020-2026 as the forecast period. The research was based on the findings of an expert team of analysts analyzing the Insulin Delivery Devices market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Insulin Delivery Devices industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening the Insulin Delivery Devices market share in developed countries.

Scope of the Research

Global Insulin Delivery Devices Market is analyzed and forecast over the outlook period from 2020 to 2026 by Product including
Insulin syringes
Insulin pens
Insulin pumps
Insulin injectors

Global Insulin Delivery Devices Market is analyzed and forecast over the outlook period from 2020 to 2026 by End-Use
Hospital
Homecare
Others

Top Companies Operating in the Insulin Delivery Devices market include Abbott Laboratories, Becton Dickinson, Biocon Ltd., Eli Lilly, F. Hoffmann-La Roche, Ltd., Insulet, Medtronic, Novo Nordisk, Sanofi, Wockhardt Ltd.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Biocon Ltd. Eli Lilly
  • Medtronic
  • Novo Nordisk
  • Sanofi
  • MORE
1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Insulin Delivery Devices Market- Key Findings, 2020

3. Strategic Imperatives on Global Insulin Delivery Devices Market
3.1 Covid-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End-user Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Insulin Delivery Devices Companies

4. Global Insulin Delivery Devices Market Value Outlook to 2026 Outlook by Product
4.1 Insulin Syringes
4.2 Insulin Pens
4.3 Insulin Pumps
4.4 Insulin Injectors

5. Global Insulin Delivery Devices Market Value Outlook to 2026 Outlook by End-Use
5.1 Hospital
5.2 Homecare
5.3 Others

6 Asia-Pacific Insulin Delivery Devices Market Value Outlook to 2026
6.1 Leading Insulin Delivery Devices Types Contributing to Asia-Pacific Market
6.2 Top Applications Contributing to Asia-Pacific Insulin Delivery Devices
6.3 Top Countries Contributing to Asia-Pacific Insulin Delivery Devices

7 Europe Insulin Delivery Devices Market Value Outlook to 2026
7.1 Leading Insulin Delivery Devices Types Contributing to Europe Market
7.2 Top Applications Contributing to Europe Insulin Delivery Devices
7.3 Top Countries Contributing to Europe Insulin Delivery Devices

8 North America Insulin Delivery Devices Market Value Outlook to 2026
8.1 Leading Insulin Delivery Devices Types Contributing to North America Market
8.2 Top Applications Contributing to North America Insulin Delivery Devices
8.3 Top Countries Contributing to North America Insulin Delivery Devices

9 South and Central America Insulin Delivery Devices Market Value Outlook to 2026
9.1 Leading Insulin Delivery Devices Types Contributing to South and Central America Market
9.2 Top Applications Contributing to South and Central America Insulin Delivery Devices
9.3 Top Countries Contributing to South and Central America Insulin Delivery Devices

10 Middle East Africa Insulin Delivery Devices Market Value Outlook to 2026
10.1 Leading Insulin Delivery Devices Types Contributing to Middle East Africa Market
10.2 Top Applications Contributing to Middle East Africa Insulin Delivery Devices
10.3 Top Countries Contributing to Middle East Africa Insulin Delivery Devices

11 Business Profiles of Leading Companies
11.1 Business Description, SWOT and Financial Analysis of Companies in Insulin Delivery Devices Market
11.2 Abbott Laboratories
11.3 Becton Dickinson
11.4 Biocon Ltd.
11.5 Eli Lilly
11.6 F. Hoffmann-La Roche, Ltd.
11.7 Insulet
11.8 Medtronic
11.9 Novo Nordisk
11.10 Sanofi
11.11 Wockhardt Ltd.

12 Recent Industry Developments

13 Appendix
13.1 Analyst Expertise
13.2 Sources and Methodology
13.3 Contacts
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Becton Dickinson
  • Biocon Ltd. Eli Lilly
  • F. Hoffmann-La Roche Ltd. Insulet
  • Medtronic
  • Novo Nordisk
  • Sanofi
  • Wockhardt Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll